849 results on '"Ingerslev, J"'
Search Results
2. Virtual surgical analysis: long-term cone beam computed tomography stability assessment of segmental bimaxillary surgery
3. Therapeutical Options for Congenital FVII Deficiency — The HK 7 Project of the International Greifswald Registry of the Congenital FVII Deficiency (GR-HK-7)
4. Psychosoziale Unterstützung für Hämophiliepatienten in Dänemark : Darmstädter Gespräche, 10. Seminar 1994
5. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders
6. Dynamic APTT parameters: applications in thrombophilia
7. Experiences with Recombinant Factor VIIa (rVIIa) in Treatment of Haemophilic Inhibitor Bleeding
8. Factor XIII combined with recombinant factor VIIa: a new means of treating severe hemophilia A
9. Efficacy of Recombinant Factor VIIa (rVIIa) in Surgical Procedures in Haemophilia A Patients with Inhibitors and Congenital Factor VII Deficiency
10. Prophylaxe und Rehabilitation - der skandinavische Weg : Darmstädter Gespräche, 11. Seminar 1995
11. Validation of a rapid test (VWF-LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM-1VWD
12. Replacement therapy in inherited factor VII deficiency: occurrence of adverse events and relation with surgery
13. Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD study
14. Mechanisms of hydroxyethyl starch‐induced dilutional coagulopathy
15. Major differences in bleeding symptoms between factor VII deficiency and hemophilia B
16. Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial
17. P–617 Idiopathic early ovarian aging: Do biomarkers of ageing indicate premenopausal accelerated biological ageing in young women with diminished response to ART?
18. Hemostatic effect of recombinant factor VIIa, NN1731 and recombinant factor VIII on needle-induced joint bleeding in hemophilia A mice
19. Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM‐1VWD)
20. Patient characteristics that influence efficacy of prophylaxis with rFVIII-FS three times per week: a subgroup analysis of the LIPLONG study
21. Inhibitors to factor VII in congenital factor VII deficiency
22. Tailoring haemostatic treatment to patient requirements – an update on monitoring haemostatic response using thrombelastography
23. Long-standing prophylactic therapy vs. episodic treatment in young people with severe haemophilia: a comparison of age-matched Danish and Russian patients
24. Tranexamic acid combined with recombinant factor VIII increases clot resistance to accelerated fibrinolysis in severe hemophilia A
25. Recombinant factor VIIa use in patients with the rarest forms of inherited coagulation-factor deficiencies: a study of cases from the www.haemostasis.com registry
26. Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM‐1VWD)
27. Differential patterns of dynamic whole blood platelet aggregation in haemophilia A following in vitro addition of rFVIII and by-passing agents: PB 3.38–4
28. Platelet activation and aggregation: the importance of thrombin activity—A laboratory model
29. Progression of haemophilic arthropathy in children: a Lithuanian – Danish comparative study
30. Endothelial dysfunction, increased inflammation, and activated coagulation in HIV-infected patients improve after initiation of highly active antiretroviral therapy
31. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor
32. Malignant disease in the haemophilic population: moving towards a management consensus?
33. Congenital Factor VII deficiency: S-TU-O1P.1-2
34. Invasive procedures and minor surgery in factor VII deficiency
35. Dynamic APTT parameters: applications in thrombophilia
36. Comparison of the effects of a monounsaturated fat diet and a high carbohydrate diet on cardiovascular risk factors in first degree relatives to type-2 diabetic subjects
37. Transcapillary escape rate and albuminuria in Type II diabetes. Effects of short-term treatment with low-molecular weight heparin (Short Communication)
38. Previously unrecognized advanced liver disease unveiled by transient elastography in patients with Haemophilia and chronic hepatitis C
39. Efficacy and safety of prophylaxis with once-weekly bay 79–4980 vs. three-times-weekly rFVIII-FS: a randomized, active-controlled, double-blind study: O-TH-016
40. Standardization of thromboelastography: a report from the TEG-ROTEM working group
41. A comparison between two semi-quantitative bleeding scales for the diagnosis and assessment of bleeding severity in type 1 von Willebrand disease
42. Muscle bleeds in professional athletes - diagnosis, classification, treatment and potential impact in patients with haemophilia
43. Current practice in the management of muscle haematomas in patients with severe haemophilia
44. Session W1.4 Factor VIII light chain mutations and cysteine substitutions predispose for inhibitor development in mild and moderate haemophilia A: first results from the INSIGHT study: 17FP05
45. Combination of recombinant factor VIIa and fibrinogen corrects the coagulopathy of idiopathic thrombocytopenic purpura: 09P14
46. NovoSeven® for surgery in inherited FVII deficiency: data from STER (Seven Treatment Evaluation Registry): 08P26
47. Haemophilia carriers: levels of FVIII or FIX: 05P08
48. Utility of the Haemophilia Joint Health Score in study of episodically treated boys with severe haemophilia A and B in Lithuania
49. A case-controlled danish-russian comparative study of clinical outcomes in younger severe haemophilia patients treated with prophylaxis compared to those managed with on-demand treatment: OC-MO-036
50. Establishment of a european network of rare bleeding disorders (EN-RBD database): preliminary results on 190 patients: AS-MO-028
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.